Some people, such as those with diabetes, are unable to produce or use insulin or glucagon effectively. In this case, healthcare providers prescribe insulin and glucagon as medications that people ...

The FDA approved Gvoke, a ready-to-use glucagon product, for the treatment of severe hypoglycemia in 2019. The format is potentially more convenient than traditional glucagon kits from the likes ...

Glucagon—like insulin ... Discovery Institute has found potential new ways to make better medicines using pre-clinical models ...

Through this important partnership, we can save lives by ensuring individuals with diabetes who are treated with insulin have access to glucagon, preferably a ready-to-use formulation, so they can ...